XML 57 R46.htm IDEA: XBRL DOCUMENT v3.26.1
COMMITMENTS AND CONTINGENCIES (Details)
$ in Millions
6 Months Ended
Jun. 30, 2026
USD ($)
Loss Contingencies [Line Items]  
Purchase obligation $ 7.0
Takeda Pharmaceuticals U.S.A., Inc.  
Loss Contingencies [Line Items]  
Licenses agreement, planned stockholder distribution from proceeds, percentage 25.00%